Skip to content

A multicenter randomized controlled study on the efficacy of electroacupuncture at ST36 on gastrointestinal dysfunction after pancreaticoduodenectomy

A multicenter randomized controlled study on the efficacy of electroacupuncture at ST36 on gastrointestinal dysfunction after pancreaticoduodenectomy

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600125794
Enrollment
Unknown
Registered
2026-06-01
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postoperative Gastrointestinal Dysfunction

Interventions

Sham electroacupuncture group:Sham electroacupuncture at ST36.
Real Electroacupuncture Group:Electroacupuncture at ST36.

Sponsors

Hospital Affiliated to Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Ages 18–75, regardless of gender; 2. Planned elective pancreaticoduodenectomy (standard pancreaticoduodenectomy procedure); 3. ASA anesthesia classification I–III; 4. No acupuncture, electrical stimulation, or other interventions received within one month before pancreaticoduodenectomy; 5. Understand the research process and sign a written informed consent form.

Exclusion criteria

Exclusion criteria: 1. Emergency or repeat surgery cases; 2. Major intraoperative complications (such as massive hemorrhage, intraoperative conversion to open surgery, postoperative ICU stay >24 hours); 3. Persons with severe cardiovascular and cerebrovascular diseases, liver and kidney dysfunction, or neurological and psychiatric disorders; 4. Persons with a pacemaker or implantable stimulator; 5. Those allergic to acupuncture or electrical stimulation, or who have previously experienced fainting from needles; 6. Pregnant or breastfeeding women; 7. Recent use of drugs that affect gastrointestinal motility (such as potent opioids, prokinetic drugs); 8. Participants deemed unsuitable by the researcher.

Design outcomes

Primary

MeasureTime frame
Time of first anorectum exhaust;

Secondary

MeasureTime frame
Incidence of delayed gastric emptying;Nutritional Risk Screening;Incidence and severity of gastrointestinal symptoms;Quality of life assessment;I-FEED;Hospitalization duration;Time of first drinking water;Time of first bowel movement;Blood Biomarker;Tolerance time for liquid and solid foods;Time of first being out of bed and time of independent walking;Assessment of Pain Intensity;

Countries

China

Contacts

Public ContactWang Nianhong

Hospital Affiliated to Fudan University

wnh2005@126.com+86 21 5288 7820

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026